Skip to content

CG Oncology CGON Return on invested capital

Return on invested capital at other companies

Pfizer logo
PfizerPFE
6%
Johnson & Johnson logo
Johnson & JohnsonJNJ
20.6%+0.3pp
Gilead Sciences logo
Gilead SciencesGILD
23.7%+4.4pp
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-147.2%-18.7pp
Tango Therapeutics logo
Tango TherapeuticsTNGX
-57.7%-11.3pp
Celcuity logo
CelcuityCELC
-168.1%-1,894pp

Other financials

Income statement

See full
Revenue$1.1M+1,983%
Operating income-$66.4M-57.3%
Net income-$60.2M-74.7%
EPS (diluted)-$0.71-57.8%

Balance sheet

See full
Cash & equivalents$33.7M-18.7%
Total debt$7.6M+631%
Total equity$1.1B+54.9%
Total assets$1.1B+55.9%

Cash flow

See full
Operating cash flow-$56.9M-94.5%
CapEx$304.0K+1,800%
Free cash flow-$57.2M-95.4%

Valuation

See full
Market cap$5.39B+206%

Profitability

See full
Operating margin-4,239%-1,872pp
Net margin-3,682.6%-1,601pp
FCF margin-3,163.8%-1,351pp

Returns & leverage

See full
Return on equity-20.8%+7.1pp
Debt / equity0.0×
Current ratio31.3×+0.3×

Where this comes from

Calculated from CG Oncology’s reported figures.

Based on trailing twelve months.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CG Oncology's return on invested capital?
CG Oncology (CGON) reported return on invested capital of -24.9% in Q1 2026.
How has CG Oncology's return on invested capital changed year-over-year?
CG Oncology's return on invested capital decreased by 6.9% year-over-year, from -23.2% to -24.9%.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.